
David Niesel
Articles
-
1 month ago |
galvnews.com | Norbert Herzog |David Niesel
Quickly and accurately identifying which microbe is causing a patient’s disease is key to developing the proper treatment. This is particularly true for infections of the central nervous system (CNS) such as meningitis, encephalitis and myelitis, which can cause severe and life-threatening disease. Scientists at the University of California San Francisco (UCSF) clinical microbiology laboratory have been testing a new method for the diagnosis of CNS infections.
-
Jan 16, 2024 |
galvnews.com | Norbert Herzog |David Niesel
Chikungunya or CHIKV is a disease that is surging in South America, and even Texas and Florida. This is just one example of an infectious disease that is spreading and increasing in incidence as a result of global warming. Yes, global warming is real and human activity is a major contributor. CHIKV is a disease caused by the Chikungunya virus.
-
Jan 9, 2024 |
galvnews.com | Norbert Herzog |David Niesel
It is devastating for parents of a newborn to learn that their child has a genetic disorder. At least the parents of one such child, Gideon Griffiths, a 5-year-old from Bellefontaine, Ohio, now have hope. If all goes well, he might be spared the worst of Duchenne’s Muscular Dystrophy (DMD) and perhaps live a longer life thanks to a new gene therapy. DMD is a neuromuscular genetic disorder caused by a mutation in the Dystrophin gene.
-
Dec 19, 2023 |
galvnews.com | Norbert Herzog |David Niesel
If you ever doubted how valuable AI could be in developing new drugs, listen to this story. It is a game-changer! Since antibiotics were developed in the 1940s, they have saved countless lives. The problem with these drugs is that bacteria can become resistant to them. To make matters worse, some bacteria become resistant to multiple antibiotics. These have been termed “super bugs” and they are difficult to impossible to effectively treat.
-
Dec 12, 2023 |
galvnews.com | Norbert Herzog |David Niesel
Tuberculosis (TB) has plagued humans for millennia and it remains a leading cause of illness and death throughout the world. Although a TB vaccine has been available for about 100 years, it does not work to prevent pulmonary TB in adolescents and adults, which is the most common form of TB. Now thanks to the combined funding of the Wellcome and the Bill and Melinda Gates Foundation, a late-phase clinical trial of a new TB vaccine candidate may finally provide a tool to control this disease.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →